Sabra Healthcare REIT (NASDAQ:SBRA) Coverage Initiated by Analysts at UBS Group

UBS Group began coverage on shares of Sabra Healthcare REIT (NASDAQ:SBRA) in a report released on Tuesday,Benzinga reports. The firm set a “neutral” rating and a $20.00 price target on the real estate investment trust’s stock. UBS Group’s price target would indicate a potential upside of 7.58% from the company’s previous close.

A number of other equities research analysts have also recently weighed in on SBRA. JMP Securities upped their price objective on Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a “market outperform” rating in a research note on Wednesday, August 6th. BMO Capital Markets boosted their target price on shares of Sabra Healthcare REIT from $19.00 to $22.00 and gave the stock a “market perform” rating in a report on Monday, August 25th. Truist Financial increased their price target on shares of Sabra Healthcare REIT from $18.00 to $20.00 and gave the company a “hold” rating in a research report on Tuesday, September 2nd. National Bankshares set a $22.00 price target on shares of Sabra Healthcare REIT in a report on Friday, October 17th. Finally, Weiss Ratings reiterated a “buy (b)” rating on shares of Sabra Healthcare REIT in a report on Wednesday, October 8th. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Sabra Healthcare REIT currently has an average rating of “Moderate Buy” and an average price target of $20.67.

Sabra Healthcare REIT Price Performance

NASDAQ SBRA opened at $18.59 on Tuesday. The company has a market cap of $4.64 billion, a PE ratio of 24.46, a P/E/G ratio of 1.10 and a beta of 0.84. The firm’s 50 day moving average price is $18.37 and its 200-day moving average price is $18.32. The company has a debt-to-equity ratio of 0.91, a quick ratio of 4.80 and a current ratio of 4.80. Sabra Healthcare REIT has a 52-week low of $15.60 and a 52-week high of $19.97.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its earnings results on Wednesday, November 5th. The real estate investment trust reported $0.38 earnings per share for the quarter, topping analysts’ consensus estimates of $0.37 by $0.01. The company had revenue of $190.04 million during the quarter, compared to analyst estimates of $193.44 million. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%.Sabra Healthcare REIT’s revenue was up 6.7% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.37 earnings per share. Sabra Healthcare REIT has set its FY 2025 guidance at 1.455-1.465 EPS. Sell-side analysts forecast that Sabra Healthcare REIT will post 1.45 EPS for the current fiscal year.

Institutional Investors Weigh In On Sabra Healthcare REIT

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Vanguard Group Inc. grew its holdings in shares of Sabra Healthcare REIT by 0.5% during the third quarter. Vanguard Group Inc. now owns 34,948,785 shares of the real estate investment trust’s stock valued at $651,445,000 after buying an additional 179,670 shares during the last quarter. Geode Capital Management LLC lifted its position in Sabra Healthcare REIT by 0.8% during the 2nd quarter. Geode Capital Management LLC now owns 6,613,185 shares of the real estate investment trust’s stock worth $121,960,000 after acquiring an additional 55,200 shares during the period. Bank of America Corp DE lifted its position in Sabra Healthcare REIT by 9.4% during the 3rd quarter. Bank of America Corp DE now owns 5,224,116 shares of the real estate investment trust’s stock worth $97,378,000 after acquiring an additional 447,528 shares during the period. Bank of New York Mellon Corp grew its stake in Sabra Healthcare REIT by 1.5% during the 2nd quarter. Bank of New York Mellon Corp now owns 4,175,058 shares of the real estate investment trust’s stock valued at $76,988,000 after purchasing an additional 60,843 shares during the last quarter. Finally, Northern Trust Corp increased its holdings in shares of Sabra Healthcare REIT by 1.1% in the third quarter. Northern Trust Corp now owns 3,930,245 shares of the real estate investment trust’s stock valued at $73,260,000 after purchasing an additional 43,927 shares during the period. 99.40% of the stock is currently owned by institutional investors and hedge funds.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.